Virtus LifeSci Biotech Products ETF
16 hedge funds and large institutions have $10.2M invested in Virtus LifeSci Biotech Products ETF in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$240K | |
| 2 | +$200K | |
| 3 | +$4.48K | |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$4K |
| 5 |
NFG
Next Financial Group
Houston,
Texas
|
+$3.37K |
Top Sellers
| 1 | -$1.9M | |
| 2 | -$185K | |
| 3 | -$76K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$55.3K |
| 5 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
-$33.1K |